Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907992 · ClinicalTrials.gov registry record
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
A clinical trial, sponsored by Augusta University.
- Not yet
- Registry status
- 150
- Enrollment target
NCT06907992 is a clinical trial that has not yet begun recruiting, run by Augusta University. The registered enrollment target is 150 participants.
The verdict
NCT06907992 has not yet begun recruiting, sponsored by Augusta University.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess whether a seven-day course of standard of care (echinocandin) antifungal therapy is non-inferior to a 14-day course of echinocandin antifungal therapy in patients with uncomplicated candidemia in terms of clinical, mycologic, adverse events and all cause mortality.
Interventions
- DRUG Antifungal treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06907992
The ClinicalTrials.gov registry entry for NCT06907992 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Antifungal treatment is the first listed.
NCT06907992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06907992 about?
NCT06907992 is a clinical study titled "A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia". The goal of this clinical trial is to assess whether a seven-day course of standard of care (echinocandin) antifungal therapy is non-inferior to a 14-day course of echinocandin antifungal therapy in patients with uncomplicated candidemia in terms of clinical, mycologic, adverse events and all cause ...
What is the current status of trial NCT06907992?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2025-05-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT06907992?
The interventions under investigation include: Antifungal treatment (DRUG).
Who is sponsoring clinical trial NCT06907992?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.